Michael Huber

Michael Huber, PD Dr., is the Head of the Research Group Huber at University Hospital Zurich, specializing in diagnostics and development. His work focuses on advanced viral diagnostics using Next-Generation Sequencing (NGS) for immunocompromised patients.

Research Interests: His research bridges virology, metagenomics, and infectious disease etiology, particularly in immunocompromised settings such as transplantation, primary immunodeficiencies, and HIV infection. He aims to improve tailored diagnostics and treatment options through viral metagenome analysis.

Scientific Contributions: Recent publications highlight virus sequence-independent amplification by random PCR combined with NGS to study emergent disease-specific viruses. These methods aim to address previously undetermined infection causes.